Insulin resistance and inflammation in chronic kidney diseases;Insulino résistance et inflammation en insuffisance rénale

Nephrologie et Therapeutique

Volumn 5, Issue SUPPL. 5, 2009, Pages

  Guebre Egziabher, Fitsum ^a,b,c   Kalbacher, Emilie ^a,b   Fouque, Denis ^a,b,c  

^a UNIVERSITÉ LYON 1   (France)

^b INSERM   (France)

^c Univ Lyon   (France)

Author keywords

Adipose tissue; Chronic renal failure; Dialysis; Inflammation; Insulin resistance

Indexed keywords

ADIPOCYTOKINE; C REACTIVE PROTEIN; CALCITRIOL; CASPASE 3; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; ANEMIA; ARTERIAL PRESSURE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CYTOKINE RELEASE; DIABETIC PATIENT; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENDOCRINE DISEASE; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; HEMODIALYSIS PATIENT; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY FAILURE; LIFESTYLE; METABOLIC ACIDOSIS; METABOLIC SYNDROME X; MOLECULAR MECHANICS; NUTRITIONAL STATUS; OXIDATIVE STRESS; PROTEIN DEGRADATION; RISK FACTOR; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; UREMIA; VITAMIN D DEFICIENCY;

CHRONIC DISEASE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; KIDNEY DISEASES; RENAL DIALYSIS;

EID: 70249087349     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1769-7255(09)75168-5     Document Type: Article

References (57)

1. Obici S., Zhang B.B., Karkanias G., and Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 8 (2002) 1376-1382
2. DeFronzo R.A., Tobin J.D., and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237 (1979) E214-E223
3. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostatis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
4. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85 (2000) 2402-2410
5. DeFronzo R.A., Alvestrand A., Smith D., Hendler R., Hendler E., and Wahren J. Insulin resistance in uremia. J Clin Invest 67 (1981) 563-568
6. DeFronzo R.A., Tobrin D., Rowe J.W., and Andres D. Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin. J Clin Invest 62 (1978) 425-435
7. Shinohara K., Shoji T., Emoto M., Tahara H., Koyama H., Ishimura E., et al. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 13 (2002) 1894-1900
8. Takenaka T., Kanno Y., Ohno Y., and Suzuki H. Key role of insulin resistance in vascular injury among hemodialysis patients. Metabolism 56 (2007) 153-159
9. McCaleb M.L., Izzo M.S., and Lockwood D.H. Characterization and partial purification of a factor from uremic human serum that induces insulin resistance. Clin Invest 75 (1985) 391-396
10. Kobayashi S., Maejima S., Ikeda T., and Nagase M. Impact of dialysis therapy on insulin resistance in end-stage renal disease: comparison of haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 15 (2000) 65-70
11. Chonchol M., and Scragg R. 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int 71 (2007) 134-139
12. Bailey J.L., Zheng B., Hu Z., Price S.R., and Mitch W.E. Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy. J Am Soc Nephrol 17 (2006) 1388-1394
13. Akmal M., Massry S.G., Goldstein D.A., Fanti P., Weisz A., and DeFronzo R.A. Role of parathyroid hormone in the glucose intolerance of chronic renal failure. J Clin Invest 75 (1985) 1037-1044
14. Sit D., Kadiroglu A.K., Yilmaz M.E., Kara I.H., and Isikoglu B. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients. Ren Fail 27 (2005) 403-407
15. DeFronzo R.A., and Beckles A.D. Glucose intolerance following chronic metabolic acidosis in man. Am J Physiol 236 (1979) E328-E334
16. Cirillo P., Sato W., Reungjui S., Heinig M., Gersch M., Sautin Y., et al. Uric acid, the metabolic syndrome, and renal disease. J Am Soc Nephrol 17 (2006) S165-S168
17. Mak R.H. 1,25-Dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uremia. Kidney Int 53 (1998) 1353-1357
18. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
19. Beddhu S., Kimmel P.L., Ramkumar N., and Cheung A.K. Associations of Metabolic Syndrome with Inflammation in CKD: Results from the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 46 (2005) 577-586
20. Kasiske B.L. Hyperlipidemia in patients with chronic renal disease. Am J Kidney Dis 32 (1998) S142-S156
21. Nishimura M., Murase M., Hashimoto T., Kobayashi H., Yamazaki S., Imai R., et al. Insulin resistance and impaired myocardial fatty acid metabolism in dialysis patients with normal coronary arteries. Kidney Int 69 (2006) 553-559
22. Chen N.X., Duan D., O'Neill K.D., and Moe S.M. High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells. Nephrol Dial Transplant 21 (2006) 3435-3442
23. Olesen P., Nguyen K., Wogensen L., Ledet T., and Rasmussen L.M. Calcification of human vascular smooth muscle cells : associations with osteoprotegerin expression and acceleration by high-dose insulin. Am J Physiol Heart Circ Physiol 292 (2007) H1058-H1064
24. Reilly M.P., Wolfe M.L., Rhodes T., Girman C., Mehta N., and Rader D.J. Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis. Circulation 110 (2004) 803-809
25. Chevalier S., Marliss E.B., Morais J.A., Lamarche M., and Gougeon R. Whole-body protein anabolic response is resistant to the action of insulin in obese women. Am J Clin Nutr 82 (2005) 355-365
26. Aparicio M., Cano N., Chauveau P., Azar R., Canaud B., Flory A., et al. Nutritional status of haemodialysis patients: a French national cooperative study. Nephrol Dial Transplant 14 (1999) 1679-1686
27. Pupim L.B., Flakoll P.J., Majchrzak K.M., Aftab Guy D.L., Stenvinkel P., and Ikizler T.A. Increased muscle protein breakdown in chronic hemodialysis patients with type 2 diabetes mellitus. Kidney Int 68 (2005) 1857-1865
28. Siew E.D., Pupim L.B., Majchrzak K.M., Shintani A., Flakoll P.J., and Ikizler T.A. Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients. Kidney Int 71 (2007) 146-152
29. Wang X., Hu Z., Hu J., Du J., and Mitch W.E. Insulin Resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 147 (2006) 4160-4168
30. Lee S.W., Park G.H., Lee S.W., Song J.H., Hong K.C., and Kim M.J. Insulin resistance and muscle waisting in non diabetic end stage renal disease patients. Nephrol Dial Transplant 22 (2007) 2554-2562
31. Pereira B.J., Shapiro L., King A.J., Falagas M.E., Strom J.A., and Dinarello C.A. Plasma levels of IL-16, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 45 (1994) 890-896
32. Zimmermann J., Herrlinger S., Pruy A., Metzger T., and Wanner C. Inflammation enhances cardivascular risk and mortality in hemodialysis patients. Kidney Int 55 (1999) 648-658
33. Pupim L.B., Caglar K., Hakim R.M., Shyr Y., and Ikizler T.A. Uremic malnutrition is a predictor of death independent of inflamatory status. Kidney Int 66 (2004) 2054-2060
34. Guarnieri G., Toigo G., Fiotti N., Ciochi B., Situlin R., Giansante C., et al. Mechanism of malnutrition in uremia. Kidney Int 62 (1997) S41-S44
35. Kaizu Y., Kimura M., Yoneyama T., Miyaji K., Hibi I., and Kumagai H. Interleukine-6 may mediate malnutrition in chronic hemodialysis patients. Am J Kidney Dis 31 (1998) 93-100
36. Bologa R.M., Levine D.M., Parker T.S., Cheigh J.S., Serur D., Stenzel K.H., and Rubin A.L. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 32 (1998) 107-114
37. Ducloux D., Bresson-Vautrin C., Kribs M., Abdelfatah A., and Chalopin J.M. C-reactive protein and cardiovascular disease in peritoneal dialysis patients. Kidney Int 62 (2002) 1417-1422
38. Stenvinkel P., Heimbürger O., Paultre F., Diczfalusy U., Wang T., Berglund L., et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55 (1999) 1899-1911
39. Balakrishnan V.S., Guo D., Rao M., Jaber B.L., Tighiouart H., Freeman R.L., et al., HEMO Study Group. Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin. Kidney Int 65 (2004) 1449-1460
40. Yudkin J.S., Stehouwer C.D., Emeis J.J., and Coppack S.W. C-reactive protein in healthy subjects : associations with obesity, insulin resistance, and endothelial dysfunction : a potential role for cytokines originating from adipose tissue ?. Arterioscler Thromb Vasc Biol 19 (1999) 972-978
41. Mohamed-Ali V., Goodrick S., Rawesh A., Katz D.R., Miles J.M., Yudkin J.S., et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82 (1997) 4196-4200
42. Wellen K.E., and Hotamisligil G.S. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112 (2003) 1785-1788
43. Marette A. Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings. Curr Opin Clin Nutr Metab Care 5 (2002) 377-383
44. Kawazoe Y., Naka T., Fujimoto M., Kohzaki H., Morita Y., Narazaki M., et al. Signal transducer and activator of transcription (STAT) -induced STAT inhibitor 1 (SSI-1) /suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation. J Exp Med 193 (2001) 263-269
45. Rieusset J., Bouzakri K., Chevillotte E., Ricard N., Jacquet D., Bastard J.P., et al. Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients. Diabetes 53 (2004) 2232-2241
46. Ravussin E., and Smith S.R. Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann N Y Acad Sci 967 (2002) 363-378
47. Benavides S., and Nahata M.C. Pharmacologic Therapy for HIV-Associated Lipodystrophy. Ann Pharmacother 38 (2004) 448-457
48. Ohman M.K., Shen Y., Obimba C.I., Wright A.P., Warnock M., Lawrence D.A., et al. Visceral Adipose Tissue Inflammation Accelerates Atherosclerosis in Apolipoprotein E- Deficient Mice. Circulation 117 (2008) 798-805
49. Zoccali C., Mallamaci F., Tripepi G., Benedetto F.A., Cutrupi S., Parlongo S., et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13 (2002) 134-141
50. Heimbürger O., lönnqvist F., Danielsson A., Nordenström J., and Stenvinkel P. Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 8 (1997) 1423-1430
51. Guebre-Egziabher F., Bernhard J., Funahashi T., Hadj-Aissa A., and Fouque D. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol Dial Transplant 20 (2005) 129-134
52. Menon V., Li L., Wang X., Greene T., Balakrishnan V., Madero M., et al. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 17 (2006) 2599-2606
53. Johansen K.L., Mulligan K., Tai V., and Schambelan M. Leptin, body composition and indices of malnutrition in patients on dialysis. J Am Soc Nephrol 9 (1998) 1080-1084
54. Axelsson J., Rashid Qureshi A., Suliman M.E., Honda H., Pecoits-Filho R., Heimburger O., et al. Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 80 (2004) 1222-1229
55. Axelsson J., Moller H.J., Witasp A., Qureshi A.R., Carrero J.J., Heimburger O., et al. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD. Am J Kidney Dis 48 (2006) 916-925
56. Kalantar-Zadeh K., Abbott K.C., Salahudeen A.K., Kilpatrick R.D., and Horwich T.B. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 81 (2005) 543-554
57. Beddhu S., Pappas L.M., Ramkumar N., and Samore M.H. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 14 (2003) 2366-2372